Northern Trust’s Acura Pharmaceuticals ACUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-12,953
| Closed | -$10K | – | 4317 |
|
|
2016
Q4 | $10K | Buy |
12,953
+108
| +0.8% | +$113 | ﹤0.01% | 4133 |
|
|
2016
Q3 | $20K | Hold |
12,845
| – | – | ﹤0.01% | 4108 |
|
|
2016
Q2 | $24K | Hold |
12,845
| – | – | ﹤0.01% | 4102 |
|
|
2016
Q1 | $36K | Hold |
12,845
| – | – | ﹤0.01% | 4065 |
|
|
2015
Q4 | $32K | Hold |
12,845
| – | – | ﹤0.01% | 4120 |
|
|
2015
Q3 | $30K | Sell |
12,845
-855
| -6% | -$2.91K | ﹤0.01% | 4150 |
|
|
2015
Q2 | $67K | Sell |
13,700
-2,102
| -13% | -$8.73K | ﹤0.01% | 4016 |
|
|
2015
Q1 | $62K | Sell |
15,802
-240
| -1% | -$766 | ﹤0.01% | 4124 |
|
|
2014
Q4 | $36K | Hold |
16,042
| – | – | ﹤0.01% | 4134 |
|
|
2014
Q3 | $63K | Sell |
16,042
-34
| -0.2% | -$160 | ﹤0.01% | 4118 |
|
|
2014
Q2 | $88K | Sell |
16,076
-56
| -0.3% | -$339 | ﹤0.01% | 4034 |
|
|
2014
Q1 | $118K | Buy |
16,132
+586
| +4% | +$5.09K | ﹤0.01% | 3910 |
|
|
2013
Q4 | $129K | Buy |
15,546
+7,703
| +98% | +$65.1K | ﹤0.01% | 3821 |
|
|
2013
Q3 | $75K | Sell |
7,843
-32,090
| -80% | -$284K | ﹤0.01% | 3868 |
|
|
2013
Q2 | $375K | Buy |
+39,933
| New | +$451K | ﹤0.01% | 3516 |
|
Other funds holding ACUR
Northern Trust's ACUR Position: Q1 2017 in Review
Northern Trust sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 12,953 shares — an estimated $10K sold.
Northern Trust first reported a position in ACUR in Q2 2013 and held it in 15 quarters. The position peaked at $375K in Q2 2013. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.
- Northern Trust reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
- Northern Trust sold 12,953 Acura Pharmaceuticals shares in Q1 2017, an estimated $10K.
- Northern Trust first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 15 quarters.
- Northern Trust's Acura Pharmaceuticals position peaked at $375K in Q2 2013.
- 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.
Based on Northern Trust's 13F filing for Q1 2017, filed 12 May 2017.